← Leaderboards
Brian C Vanderven
Cornell University
$7,523,719
Attributed
$7,523,719
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,523,719 · 5
By mechanism
R01$7,098,094 · 4
R21$425,625 · 1
Top collaborators
No co-investigators on record.
Most similar at Cornell University
Same institution · by research overlap
- Robert B Abramovitch$8,804,658
- Shumin Tan$5,376,338
- Steven E Ealick$100,000
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaCessation Of LifeTuberculosisMacrophageCholesterolPathway InteractionsMycobacterium TuberculosisInfectionDrug DevelopmentPathogenesisMutantImmune ResponseDrug TargetingComplexGranulomaMetabolic PathwayIn VivoMouse ModelMetabolicPositioning AttributeImmuneEnzymesCholesterol HomeostasisVirulence
Grant awards (16)
Novel therapeutics to treat TB by stimulating bacterial cAMP production$746,602
R01 · FY2025 · AI · contact PI
Characterization of the nutrient assimilation pathways in M. tuberculosis$527,826
R01 · FY2025 · AI · contact PI
Characterization of the nutrient assimilation pathways in M. tuberculosis$598,288
R01 · FY2024 · AI · contact PI
Characterization of the nutrient assimilation pathways in M. tuberculosis$598,288
R01 · FY2023 · AI · contact PI
Characterization of the nutrient assimilation pathways in M. tuberculosis$640,202
R01 · FY2022 · AI · contact PI
Characterization of the nutrient assimilation pathways in M. tuberculosis$571,814
R01 · FY2021 · AI · contact PI
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.$440,175
R01 · FY2021 · AI · contact PI
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.$440,175
R01 · FY2020 · AI · contact PI
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.$456,622
R01 · FY2019 · AI · contact PI
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.$461,332
R01 · FY2018 · AI · contact PI
Preclinical evaluation of compounds that inhibit cholesterol uptake in M. tuberculosis.$454,270
R01 · FY2017 · AI · contact PI
Exploiting metabolic toxicities to identify compounds that inhibit cholesterol metabolism in M. Tuberculosis$387,500
R01 · FY2017 · AI · contact PI
Exploiting metabolic toxicities to identify compounds that inhibit cholesterol metabolism in M. Tuberculosis$387,500
R01 · FY2016 · AI · contact PI
Exploiting metabolic toxicities to identify compounds that inhibit cholesterol metabolism in M. Tuberculosis$387,500
R01 · FY2015 · AI · contact PI
Analysis of host-derived nutrient utilization pathways in M. tuberculosis$193,750
R21 · FY2014 · AI · contact PI
Analysis of host-derived nutrient utilization pathways in M. tuberculosis$231,875
R21 · FY2013 · AI · contact PI